Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02593162
Recruitment Status : Completed
First Posted : October 30, 2015
Last Update Posted : January 30, 2017
Sponsor:
Information provided by (Responsible Party):
Trek Therapeutics, PBC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016